BioSpace News Archive

Eagle expects to file a supplement to the current NDA for the treatment of brain damage secondary to nerve agent exposure in the second half of 2020

Neon Therapeutics, Inc., a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, reported financial results for the third quarter ended September 30, 2019 and provided a business update.

Helius Medical Technologies, Inc., a neurotech company focused on neurological wellness, reported financial results for the quarter ended September 30, 2019.

Establishment Labs Holdings Inc., a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced its financial results for the third quarter ended September 30, 2019.

Zynerba Pharmaceuticals, Inc. announced that the U.S. Patent and Trademark Office has issued US Patent No. 10,471,022, titled “Treatment of Fragile X Syndrome with Cannabidiol” which includes claims directed to a method of treating Fragile X syndrome, comprising transdermally administering 250 mg or 500 mg of cannabidiol daily via a gel or cream.

Biostage, Inc., a bioengineering company developing next-generation esophageal implants, announced its financial results for the three and nine months ended September 30, 2019.

CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products, reported financial results for the third quarter and nine months ended September 30, 2019.

Partnership Gives Employees and Dependents of Fortune 500 Employers in the New York City and Philadelphia Area Easy Access to an Internationally Recognized Leader In Orthopaedic Care, Expands Carrum Health’s Footprint on the East Coast

Based on these positive results, Lilly has submitted for U.S. regulatory approval for adults with active non-radiographic axial spondyloarthritis

G1 Therapeutics, Inc., a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D. will present a company overview at the Stifel Healthcare Conference.